10170 Church Ranch Way
Suite 100
Westminster, CO 80021
United States
720 940 2200
https://www.arcabio.com
版塊: Healthcare
行業: Biotechnology
全職員工: 4
名稱 | 頭銜 | 支付 | 行使價 | 出生年份 |
---|---|---|---|---|
Mr. Thomas A. Keuer | President, COO & Principal Executive Officer | 400.8k | 無 | 1959 |
Mr. C. Jeffrey Dekker CPA | CFO, Treasurer & Company Secretary | 323.07k | 無 | 1965 |
ARCA biopharma, Inc., a clinical stage biopharmaceutical company, engages in the development and commercialization of targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase IIb trial for the treatment of atrial fibrillation in patients with heart failure. It is developing Recombinant Nematode Anticoagulant Protein c2, a protein therapeutic that is in Phase IIb clinical trial for the treatment for COVID-19. The company has a collaboration agreement with LabCorp to develop genetic test for GENETIC-AF clinical trial. ARCA biopharma, Inc. is headquartered in Westminster, Colorado.
截至 無 止,ARCA biopharma, Inc. 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中:無;董事會:無;股東權利:無;現金賠償:無。